(Z)-2-(((1,5-Bis(benzhydryloxy)-4-oxo-1,4-dihydropyridin-2-yl)methoxy)imino)-2-(2-(tritylamino)thiazol-4-yl)acetic acid

Catalog No. :
ACLQYY092
CAS No. :
114875-61-5
Molecular Formula :
C56H44N4O6S
Molecular Weight :
901.06

IUPAC Name:(Z)-2-(((1,5-bis(benzhydryloxy)-4-oxo-1,4-dihydropyridin-2-yl)methoxy)imino)-2-(2-(tritylamino)thiazol-4-yl)acetic acid

(Z)-2-(((1,5-Bis(benzhydryloxy)-4-oxo-1,4-dihydropyridin-2-yl)methoxy)imino)-2-(2-(tritylamino)thiazol-4-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$1908.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(Z)-2-(((1,5-Bis(benzhydryloxy)-4-oxo-1,4-dihydropyridin-2-yl)methoxy)imino)-2-(2-(tritylamino)thiazol-4-yl)acetic acid
IUPAC Name(Z)-2-(((1,5-bis(benzhydryloxy)-4-oxo-1,4-dihydropyridin-2-yl)methoxy)imino)-2-(2-(tritylamino)thiazol-4-yl)acetic acid
Molecular FormulaC56H44N4O6S
Molecular Weight901.06
SMILESO=C(O)/C(C1=CSC(NC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)=N1)=N\OCC5=CC(C(OC(C6=CC=CC=C6)C7=CC=CC=C7)=CN5OC(C8=CC=CC=C8)C9=CC=CC=C9)=O
InChI KeySXDYOYPUHCXMTQ-GIHZUKBFSA-N
Synonym4-Thiazoleacetic acid, α-[[[1,5-bis(diphenylmethoxy)-1,4-dihydro-4-oxo-2-pyridinyl]methoxy]imino]-2-[(triphenylmethyl)amino]-, (αZ)-;(Z)-1,5-Bis-benzhydryloxy-4-oxo-1,4-dihydro-pyridin-2-ylmethoxyimino]-[2-(trityl-amino)-thiazol-4-yl]-acetic acid
CAS No.114875-61-5

Synthetic Route by SureRoute

1. ACLQYY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLQYY092 route product structure diagram
    ACLQYY092114875-61-5
Inquiry

2. ACLQYY092 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLQYY092 route product structure diagram
    ACLQYY092114875-61-5
Inquiry

Comments (0)